Latest News in the pharma Industry

Market News

CPhI Worldwide experts propose new FDA quality metrics system and recommend critical formulation attributes

CPhI Worldwide experts propose new FDA quality metrics system and recommend critical formulation attributes

26 Sep 2016

Continuous processing at a ‘tipping point’, with CDMO implementation over next 3 years, but the industry needs a better definition of what ‘continuous’ means.

Read more 
Cambrex to enhance its portfolio of small molecule API services

Cambrex to enhance its portfolio of small molecule API services

26 Sep 2016

Acquisition of PharmaCore’s portfolio also complements Cambrex's existing large-scale, multi-purpose manufacturing facilities in the US and Europe.

Read more 
Pfizer decides to remain as one company

Pfizer decides to remain as one company

26 Sep 2016

Company to continue to operate as one company with two distinct and complementary businesses to retain operating strength and financial flexibility.

Read more 
CPhI Worldwide announces the finalists of the CPhI Pharma Awards 2016

CPhI Worldwide announces the finalists of the CPhI Pharma Awards 2016

26 Sep 2016

Read more 
BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika

BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika

26 Sep 2016

Funds will be used for Phase II development and manufacturing.

Read more 
Merck to showcase innovative excipients and Emprove Program at CPhI Worldwide

Merck to showcase innovative excipients and Emprove Program at CPhI Worldwide

25 Sep 2016

Innovative excipients for controlled release including, new biodegradable, biocompatible polymers for sustained release injectables and Parteck SRP 80 for oral solid formulation.

Read more 
Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance

Leading pharmaceutical companies present industry roadmap to combat antimicrobial resistance

25 Sep 2016

Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance.

Read more 
Saneca Pharma strengthens senior team

Saneca Pharma strengthens senior team

23 Sep 2016

Jeremy Drummond will focus on growing the CDMO’s API and finished dosage form development and manufacturing business in Europe and North America.

Read more 
Dow and Colorcon extend and broaden the scope of the Controlled Release Alliance

Dow and Colorcon extend and broaden the scope of the Controlled Release Alliance

22 Sep 2016

Alliance will be extended to include Dow’s advanced technology-based pharmaceutical excipients.

Read more 
Moderna to build fully integrated GMP mRNA clinical manufacturing facility in Norwood, Mass.

Moderna to build fully integrated GMP mRNA clinical manufacturing facility in Norwood, Mass.

22 Sep 2016

Fully integrated site from raw material to API, formulation, filling and finish.

Read more 
Eleven Biotherapeutics acquires Viventia Bio to create targeted protein therapeutics oncology company

Eleven Biotherapeutics acquires Viventia Bio to create targeted protein therapeutics oncology company

21 Sep 2016

Viventia’s Lead Product Candidate, ViciniumTM, being developed for high-grade non-muscle invasive bladder cancer, with topline Phase 3 data expected in 1H 2018.

Read more 
GE to invest €150 million in biopharmaceutical manufacturing campus in Ireland

GE to invest €150 million in biopharmaceutical manufacturing campus in Ireland

21 Sep 2016

Company also in the process of setting up a training collaboration with National Institute for Bioprocessing Research and Training (NIBRT) to develop skills for Ireland’s biologics sector, training 1,500 professionals per year.

Read more